458 results on '"Byrum, Stephanie D"'
Search Results
2. TNRC18 engages H3K9me3 to mediate silencing of endogenous retrotransposons
3. Mitochondrial protein deacetylation by SIRT3 in osteoclasts promotes bone resorption with aging in female mice
4. A three-dimensional valve-on-chip microphysiological system implicates cell cycle progression, cholesterol metabolism and protein homeostasis in early calcific aortic valve disease progression
5. Targeting mitochondria in the aged cerebral vasculature with SS-31, a proteomic study of brain microvessels
6. Antiviral responses in a Jamaican fruit bat intestinal organoid model of SARS-CoV-2 infection
7. Expression of integrin β-7 is epigenetically enhanced in multiple myeloma subgroups with high-risk cytogenetics
8. Anti-PD-1/L1 lead-in before MAPK inhibitor combination maximizes antitumor immunity and efficacy
9. Durable Suppression of Acquired MEK Inhibitor Resistance in Cancer by Sequestering MEK from ERK and Promoting Antitumor T-cell Immunity
10. Discovery of a dual WDR5 and Ikaros PROTAC degrader as an anti-cancer therapeutic
11. Metaproteomics reveals potential mechanisms by which dietary resistant starch supplementation attenuates chronic kidney disease progression in rats.
12. Effect of excess weight and insulin resistance on DNA methylation in prepubertal children
13. A NSD3-targeted PROTAC suppresses NSD3 and cMyc oncogenic nodes in cancer cells
14. Table S9 from Bifunctional Inhibitor Reveals NEK2 as a Therapeutic Target and Regulator of Oncogenic Pathways in Lymphoma
15. Figure S4 from Bifunctional Inhibitor Reveals NEK2 as a Therapeutic Target and Regulator of Oncogenic Pathways in Lymphoma
16. Supplemental methods from Bifunctional Inhibitor Reveals NEK2 as a Therapeutic Target and Regulator of Oncogenic Pathways in Lymphoma
17. Data from Bifunctional Inhibitor Reveals NEK2 as a Therapeutic Target and Regulator of Oncogenic Pathways in Lymphoma
18. Supplementary Figures and Tables from Bifunctional Inhibitor Reveals NEK2 as a Therapeutic Target and Regulator of Oncogenic Pathways in Lymphoma
19. Supplementary Data - Tables from Bifunctional Inhibitor Reveals NEK2 as a Therapeutic Target and Regulator of Oncogenic Pathways in Lymphoma
20. Dysbiotic stress increases the sensitivity of the tumor vasculature to radiotherapy and c-Met inhibitors
21. PHF19 inhibition as a therapeutic target in multiple myeloma
22. Phase separation drives aberrant chromatin looping and cancer development
23. Understanding proteome quantification in an interactive learning module on Google Cloud Platform.
24. Trichloroethylene metabolite modulates DNA methylation-dependent gene expression in Th1-polarized CD4+ T cells from autoimmune-prone mice.
25. Deficiency of N-glycanase 1 perturbs neurogenesis and cerebral development modeled by human organoids
26. Anterior Pituitary Transcriptomics Following a High-Fat Diet: Impact of Oxidative Stress on Cell Metabolism
27. Proteomic Changes in Mouse Spleen after Radiation-Induced Injury and its Modulation by Gamma-Tocotrienol
28. ZMYND11-MBTD1 induces leukemogenesis through hijacking NuA4/TIP60 acetyltransferase complex and a PWWP-mediated chromatin association mechanism
29. PTMViz: a tool for analyzing and visualizing histone post translational modification data
30. Proteomic measures of gamma oscillations
31. Anterior Pituitary Transcriptomics Following a High-Fat Diet: Impact of Oxidative Stress on Cell Metabolism.
32. Bifunctional inhibitor reveals NEK2 as a therapeutic target and regulator of oncogenic pathways in lymphoma
33. Exosomal MicroRNA and Protein Profiles of Hepatitis B Virus-Related Hepatocellular Carcinoma Cells
34. Musashi exerts control of gonadotrope target mRNA translation during the mouse estrous cycle
35. CDK8 and CDK19: positive regulators of signal-induced transcription and negative regulators of Mediator complex proteins
36. Both the Infection Status and Inflammatory Microenvironment Induce Transcriptional Remodeling in Macrophages in Murine Leishmanial Lesions
37. 1,3-Butadiene-induced mitochondrial dysfunction is correlated with mitochondrial CYP2E1 activity in Collaborative Cross mice
38. Proteogenomic analysis of melanoma brain metastases from distinct anatomical sites identifies pathways of metastatic progression
39. Maternal undernutrition results in transcript changes in male offspring that may promote resistance to high fat diet induced weight gain.
40. Characterization of methionine dependence in melanoma cells
41. Data from Durable Suppression of Acquired MEK Inhibitor Resistance in Cancer by Sequestering MEK from ERK and Promoting Antitumor T-cell Immunity
42. Supplementary Table S2 from Durable Suppression of Acquired MEK Inhibitor Resistance in Cancer by Sequestering MEK from ERK and Promoting Antitumor T-cell Immunity
43. Supplementary Data from Durable Suppression of Acquired MEK Inhibitor Resistance in Cancer by Sequestering MEK from ERK and Promoting Antitumor T-cell Immunity
44. Upregulated microRNA-21 drives proliferation of lymphatic malformation endothelial cells by inhibiting PDCD4
45. Data from Loss of E-Cadherin Inhibits CD103 Antitumor Activity and Reduces Checkpoint Blockade Responsiveness in Melanoma
46. Supplementary Data from Raman Spectroscopy and Machine Learning Reveals Early Tumor Microenvironmental Changes Induced by Immunotherapy
47. Supplementary Materials from Epigenetic Control of Cdkn2a.Arf Protects Tumor-Infiltrating Lymphocytes from Metabolic Exhaustion
48. Data from Epigenetic Control of Cdkn2a.Arf Protects Tumor-Infiltrating Lymphocytes from Metabolic Exhaustion
49. Severe Acute Respiratory Syndrome Coronavirus-2 Lambda Variant Collected from a Child from Arkansas and Sequenced
50. Cutting-Edge Technologies Driving Quantitative Mass Spectrometry
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.